Management of Parapneumonic Effusions
نویسندگان
چکیده
منابع مشابه
The management of parapneumonic effusions and empyema.
Background: In normal subjects, and patients with obstructive and restrictive lung defects, flows during an FVC manoeuver are higher after a fast inspiration without an end-inspiratory pause as compared to a slow inspiration with an end-inspiratory pause of approximately 5 s (time dependence of FVC). Objective: In the present study, we investigated the influence of these two manoeuvres on PEF a...
متن کاملThoracoscopic Management of Complicated Parapneumonic Effusions in Young Children
Method: Eleven patients under the age of two year with the diagnosis of complicated parapneumonic effusions underwent thoracoscopic management. The patients had chest X-ray, Ultrasound and CT scan of the chest. The patients received antibiotic 3-6 weeks prior to thoracoscopy without improvement. The patients received fibrinolytic agent on the second postoperative day. Three trocars used, one 5 ...
متن کاملIntrapleural therapy in management of complicated parapneumonic effusions and empyema
Empyema thoracis causes high mortality, and its incidence is increasing in both children and adults. Parapneumonic effusions (PPEs) develop in about one-half of patients hospitalized with pneumonia, and their presence increases mortality by about four-fold. PPEs can be divided into simple PPEs, complicated PPEs, and frank empyema. Two guideline statements on the management of PPEs in adults hav...
متن کاملDiagnosis and management of parapneumonic effusions and empyema.
Approximately 1 million patients develop parapneumonic effusions (PPEs) annually in the United States. The outcome of these effusions is related to the interval between the onset of clinical symptoms and presentation to the physician, comorbidities, and timely management. Early antibiotic treatment usually prevents the development of a PPE and its progression to a complicated PPE and empyema. P...
متن کاملFibrinolytics in parapneumonic effusions/empyemas.
We read with interest the point/counterpoint debate by Drs Corcoran, Rahman, Colice, and Idell in CHEST (January 2014) 1 4 regarding thrombolytics in parapneumonic eff usions (PPEs)/empyemas. We have treated . 400 patients with PPEs and empyemas with intrapleural tissue plasminogen activator (tPA), and only four patients with chronic empyema needed decortication. We published two articles; one ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical and Analytical Medicine
سال: 2010
ISSN: 1309-0720,1309-2014
DOI: 10.4328/jcam.182